Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial.
Anastasia SuraevRonald R GrunsteinNathaniel S MarshallAngela L D'RozarioChristopher J GordonDelwyn J BartlettKeith WongBrendon J YeeRyan VandreyChris IrwinJonathon C ArnoldIain S McGregorCamilla M HoyosPublished in: BMJ open (2020)
ANZCTRN12619000714189.